synthetic oligonucleotides
Twist Bioscience Raises FY2023 Revenue Guidance on Higher NGS Sales
The revised expectations came as the firm reported 14 percent growth in fiscal Q3 revenues, beating Wall Street estimates on the top and bottom lines.
Atantares Closes Early Financing Rounds, Raising RMB 100M
The Beijing-based firm is developing semiconductor chips for use in biotechnology, including high-throughput DNA synthesis.
Camena Bioscience Closes $10M Series A Financing Round
The UK-based synthetic biology startup said it will use the funding to scale its operations and to further develop its gSynth enzymatic DNA synthesis platform.
The Bay Area company counts Ginkgo Bioworks among its customers for synthetic DNA molecules between 1 Kb and 7 Kb long.
EnPlusOne Biosciences Nabs Exclusive License to RNA Synthesis Technology from Wyss Institute
EnPlusOne Bio has secured a worldwide license to the ezRNA platform developed in the lab of George Church, one of the firm's cofounders.